Your browser doesn't support javascript.
Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain.
Videla, Sebastián; Otero, Aurema; Martí, Sara; Domínguez, M Ángeles; Fabrellas, Nuria; Delgado-Hito, M Pilar; Cruz, Imma; Tebé, Cristian; Vinuesa, Teresa; Ardila, Fernando; Sancho, Marta; Fernández, Esteve; Figuerola, Montserrat; Ciruela, Francisco.
  • Videla S; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Otero A; Clinical Research Support Unit (HUB-IDIBELL), Clinical Pharmacology Department, Bellvitge University Hospital, L'Hospitalet del Llobregat, 08907 Barcelona, Spain.
  • Martí S; Clinical Research Support Unit (HUB-IDIBELL), Clinical Pharmacology Department, Bellvitge University Hospital, L'Hospitalet del Llobregat, 08907 Barcelona, Spain.
  • Domínguez MÁ; Microbiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Fabrellas N; Microbiology Department, Bellvitge University Hospital, L'Hospitalet del Llobregat, 08907 Barcelona, Spain.
  • Delgado-Hito MP; Consortium for Biomedical Research in Respiratory Diseases (CIBERES), 28029 Madrid, Spain.
  • Cruz I; Microbiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Tebé C; Microbiology Department, Bellvitge University Hospital, L'Hospitalet del Llobregat, 08907 Barcelona, Spain.
  • Vinuesa T; Department of Public Health Nursing, Mental Health and Maternal and Childhood, School of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain.
  • Ardila F; Department of Fundamental and Medical-Surgical Nursing, School of Medicine and Health Sciences, GRIN-IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Sancho M; OSSMA (Oficina de Seguretat, Salut i Medi Ambient), University of Barcelona, 08028 Barcelona, Spain.
  • Fernández E; Biostatistical Unit, Department of Clinical Sciences, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Figuerola M; Microbiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Ciruela F; UICEC-IDIBELL (Clinical Research Organization), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Int J Environ Res Public Health ; 18(12)2021 Jun 17.
Article in English | MEDLINE | ID: covidwho-1273437
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities' daily life, and the University of Barcelona (UB) was not an exception. Accordingly, we aimed to determine the impact of the SARS-CoV-2 pandemic at the UB. To that end, we performed a cross-sectional study on a sample of 2784 UB members (n = 52,529). Participants answered a brief, ad hoc, online epidemiological questionnaire and provided a nasal swab for reverse transcription polymerase chain reaction (RT-PCR) SARS-CoV-2 analysis and a venous blood sample for SARS-CoV-2 IgG antibody assay. Total prevalence of SARS-CoV-2 infection (positive RT-PCR or positive IgG) was 14.9% (95%CI 13.3 to 17.0%). Forty-four participants (1.6%, 95%CI 1.2-2.1%) were positive for SARS-CoV-2 RT-PCR. IgG against SARS-CoV-2 was observed in 12.8% (95%CI 11.6-14.1%) of participants. Overall, while waiting for population vaccination and/or increased herd immunity, we should concentrate on identifying and isolating new cases and their contacts.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: Ijerph18126526

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: Ijerph18126526